Navigation Links
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Date:5/5/2008

time, Ms. Schwalm gained experience in oncology commercialization and also developed sales and marketing expertise in critical care, neurology/analgesia and gastroenterology. In her last assignment at J&J, she spent several years in the United Kingdom as the Managing Director of Ortho Biotech UK & Ireland.

Ms. Schwalm holds a Bachelor of Science degree in nursing from the University of Delaware and a Master of Business Administration degree from the Wharton School, University of Pennsylvania.

About Eisai Corporation of North America

Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd. and supports the activities of its operating companies in North America. These operating companies include: Eisai Research Institute of Boston, Inc., a discovery operation with strong organic chemistry capabilities; Morphotek, Inc., a biopharmaceutical company specializing in the development of therapeutic monoclonal antibodies; Eisai Medical Research Inc., a clinical development group; Eisai Inc., a commercial operation with manufacturing and marketing/sales functions; MGI PHARMA, Inc., an R&D and commercial operation with manufacturing and marketing/sales functions; and Eisai Machinery U.S.A., which markets and maintains pharmaceutical manufacturing machinery. For more information about Eisai, please visit http://www.eisai.com.


'/>"/>
SOURCE Eisai Corporation of North America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
2. Eisai/Pfizers Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimers Disease
3. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
4. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
5. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
6. BioElectronics Corporation Receives Major Orders From Italian Distributor
7. Oxford Finance Corporation and Comerica Bank Provide $15 Million Loan Facility to VisualSonics Inc.
8. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
9. Syndexa Pharmaceuticals Corporation and ChemDiv, Inc. Announce Discovery Collaboration
10. Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
11. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... -- Sequenom, Inc. (Nasdaq: SQNM ), today ... Mr. David Pendarvis to its board of directors. ... Kenneth F. Buechler, Ph.D., was president, chief scientific ... to 1994, Dr. Buechler was Biosite,s director of ... a senior research scientist for the diagnostics research ...
(Date:12/16/2009)... Germany, December 16 Eppendorf has ... and Verigene(R) SP systems for,infringement of European ... "Method for the,identification and/or the quantification of ... and all imports of the respective products ... authorities are required to confiscate any,violating products. ...
(Date:12/15/2009)... SAN MARINO, Calif., Dec. 15 Epeius ... of targeted genetic medicine, gained international validation of ... Rexin-G , when scientists around the world ... be a major locus of cancer pathogenesis and ... anti-cancer therapies. Recently, scientists at the NIH National ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... 25 NuVasive, Inc. (Nasdaq:,NUVA), a medical device company ... the spine, announced today,details relating to its fourth quarter ... on Tuesday, February 19, 2008, after,the close of the ... Tuesday, February 19, 2008 at,5:30 p.m. ET / 2:30 ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... of a second generation oral niacin receptor agonist,under a ... of atherosclerosis and other disorders. The initiation of this,trial ... very pleased with the progress of this collaboration,investigating the ...
... 24 ,Exelixis, Inc. (Nasdaq: EXEL ) announced today ... of Exelixis, will present at,the 2008 Wachovia Healthcare Conference ... January 31, 2008., The presentation will be webcast ... Investors on the Exelixis website at, http://www.exelixis.com ., ...
Other Biology Technology:NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results 2NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc. 3
(Date:12/15/2009)... Extinct woolly mammoths and ancient American horses may ... several thousand years longer than previously thought. After ... Alaska, a team of researchers used cutting-edge techniques ... in permafrost samples dated to between 7,600 and ... at least one population of these now-extinct mammals ...
(Date:12/15/2009)... and economic toll on society. It is estimated that ... in U.S. waters and it,s likely that rip currents account ... disconnect exists between rip current research and public understanding. ... and more importantly, most people do not know how to ... The goal of the Rip Current Symposium is to identify ...
(Date:12/14/2009)... AlaskaScientists have identified a novel antifreeze molecule in a ... 100 degrees Fahrenheit. Unlike all previously described biological antifreezes ... little or no protein. It is composed of a ... new places within the cells of organisms. , ... this molecule is a whole new kind of antifreeze ...
Breaking Biology News(10 mins):Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Scientists isolate new antifreeze molecule in Alaska beetle 2AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 1AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 2AIMS Benefit Solutions Offering Long Term Care Insurance Featuring CASH First 28TM 29 from United of Omaha 62932 3Your Online Resource For Plastic Surgery Information 62930 1Your Online Resource For Plastic Surgery Information 62930 2Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 1Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 2
... owls. The variation in individual circadian rhythms ... fact. But, until now, to systematically study circadian ... underlying genetic causes), scientists have had to rely ... and identify circadian rhythm variations in humans, the ...
... A common chemical used in the manufacturing and pharmaceutical ... and prevent heart failure in mice with the genetic ... at the University of Michigan Medical School. , The ... of skeletal muscles seen in people with MD. But ...
... discovered that chickens raised for meat can choose whether ... themselves or their eggs. , That phenomenon of 'reproductive ... out how to deal with less productive hens that ... bodies. "They like to be a little bit more ...
Other Biology News:A novel method to measure circadian cycles 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 2Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 3Chemical 'band-aid' prevents heart failure in mice with muscular dystrophy 4What comes first…the chicken, the egg, or the bad attitude? 2
... MULTI-FUN Incubator is a compact benchtop ... a microprocessor controller with a large ... and agitation speed. Air circulation inside ... incubator. Temperature can be easily calibrated ...
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
... --- a cocktail of 3 siRNAs specifically ... our most popular product. The siTrio reagent ... of your target gene when used under ... and confirmation of optimal transfection with one ...
... is a compact benchtop and stackable ... controller with a large display screen ... speed. Air circulation inside to evenly ... can be easily calibrated from the ...
Biology Products: